Treatment of intermediate-and high-grade non-Hodgkins lymphoma with anti-CD20 antibody

Treatment of intermediate-and high-grade non-Hodgkins lymphoma with anti-CD20 antibody

CN
  • CN 1,374,870 B
  • Filed: 08/02/2000
  • Issued: 01/25/2012
  • Est. Priority Date: 08/11/1999
  • Status: Active Grant
First Claim
Patent Images

1. anti-CD 20 antibodies or its are treated effective fragment and are used in combination the purposes in the preparation medicine with chemotherapy regimen CHOP, and said medicine is used for treating human patients dispersivity large celllymphoma, and wherein said lymphoma accompanies with the bulk pathological changes.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×